{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:39:40Z","timestamp":1778755180760,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13256-017-1238-y","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T11:29:27Z","timestamp":1489058967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The undifferentiated carcinoma that became a melanoma: Re-biopsy of a cancer of an unknown primary site: a case report"],"prefix":"10.1186","volume":"11","author":[{"given":"Oluf Dimitri","family":"R\u00f8e","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sissel Gyrid Freim","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"issue":"Suppl 5","key":"1238_CR1","doi-asserted-by":"crossref","first-page":"v133","DOI":"10.1093\/annonc\/mdv305","volume":"26","author":"K Fizazi","year":"2015","unstructured":"Fizazi K, Greco FA, Pavlidis N, Daugaard G, Oien K, et al. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v133\u2013138.","journal-title":"Ann Oncol"},{"key":"1238_CR2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","volume":"379","author":"N Pavlidis","year":"2012","unstructured":"Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet. 2012;379:1428\u201335.","journal-title":"Lancet"},{"key":"1238_CR3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/0284186X.2013.783230","volume":"53","author":"OT Brustugun","year":"2014","unstructured":"Brustugun OT, Helland A. Rapid reduction in the incidence of cancer of unknown primary. A population-based study. Acta Oncol. 2014;53:134\u20137.","journal-title":"Acta Oncol"},{"key":"1238_CR4","doi-asserted-by":"publisher","unstructured":"Karapetis CS, Guccione L, Tattersall MH, Gooden H, Vajdic CM, et al. Perceptions of cancer of unknown primary site - a national survey of Australian medical oncologists. Intern Med J. 2017. doi: 10.1111\/imj.13373 .","DOI":"10.1111\/imj.13373"},{"key":"1238_CR5","first-page":"3403","volume":"5","author":"KR Hess","year":"1999","unstructured":"Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin Cancer Res. 1999;5:3403\u201310.","journal-title":"Clin Cancer Res"},{"key":"1238_CR6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/CEJ.0b013e3283523468","volume":"21","author":"M Bevier","year":"2012","unstructured":"Bevier M, Sundquist J, Hemminki K. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis. Eur J Cancer Prev. 2012;21:596\u2013601.","journal-title":"Eur J Cancer Prev"},{"key":"1238_CR7","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/annonc\/mdr536","volume":"23","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Bevier M, Hemminki A, Sundquist J. Survival in cancer of unknown primary site: population-based analysis by site and histology. Ann Oncol. 2012;23:1854\u201363.","journal-title":"Ann Oncol"},{"issue":"2","key":"1238_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PAS.0000000000000527","volume":"40","author":"A Agaimy","year":"2016","unstructured":"Agaimy A, Specht K, Stoehr R, Lorey T, Markl B, et al. Metastatic malignant melanoma with complete loss of differentiation markers (Undifferentiated\/Dedifferentiated Melanoma): analysis of 14 patients emphasizing phenotypic plasticity and the value of molecular testing as surrogate diagnostic marker. Am J Surg Pathol. 2016;40(2):181\u201391.","journal-title":"Am J Surg Pathol"},{"key":"1238_CR9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/modpathol.2015.62","volume":"28","author":"RC Romano","year":"2015","unstructured":"Romano RC, Carter JM, Folpe AL. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases. Mod Pathol. 2015;28:1033\u201342.","journal-title":"Mod Pathol"},{"key":"1238_CR10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949\u201354.","journal-title":"Nature"},{"key":"1238_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/erc.1.0978","volume":"12","author":"M Xing","year":"2005","unstructured":"Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005;12:245\u201362.","journal-title":"Endocr Relat Cancer"},{"key":"1238_CR12","first-page":"374","volume":"27","author":"M Yushak","year":"2013","unstructured":"Yushak M, Kluger HM, Sznol M. Advances in the systemic treatment of metastatic melanoma. Oncology (Williston Park). 2013;27:374\u201381.","journal-title":"Oncology (Williston Park)"},{"key":"1238_CR13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ctrv.2014.06.012","volume":"40","author":"D McDermott","year":"2014","unstructured":"McDermott D, Lebbe C, Hodi FS, Maio M, Weber JS, et al. Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma. Cancer Treat Rev. 2014;40:1056\u201364.","journal-title":"Cancer Treat Rev"},{"key":"1238_CR14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"AM Eggermont","year":"2014","unstructured":"Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014;383:816\u201327.","journal-title":"Lancet"},{"key":"1238_CR15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","volume":"386","author":"GV Long","year":"2015","unstructured":"Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, et al. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Lancet. 2015;386:444\u201351.","journal-title":"Lancet"},{"key":"1238_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.critrevonc.2016.02.001","volume":"100","author":"S Gandini","year":"2016","unstructured":"Gandini S, Massi D, Mandala M. PD-L1 expression in cancer patients receiving anti PD-1\/PD-L1 antibodies: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2016;100:88\u201398.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1238_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11864-016-0414-4","volume":"17","author":"D Quiroga","year":"2016","unstructured":"Quiroga D, Lyerly HK, Morse MA. Deficient mismatch repair and the role of immunotherapy in metastatic colorectal cancer. Curr Treat Options Oncol. 2016;17:41.","journal-title":"Curr Treat Options Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-017-1238-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T19:34:58Z","timestamp":1658777698000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-017-1238-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1238"],"URL":"https:\/\/doi.org\/10.1186\/s13256-017-1238-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,27]]},"article-number":"82"}}